Program Delivery Lead
UCB Inc. | |
| |
2100 Lake Park Drive (Show on map) | |
Aug 07, 2026 | |
|
JOB DESCRIPTION Make your mark for patients We are looking for a Program Delivery Lead who is strategic, collaborative, and patient-focused to join our Global Clinical Sciences & Operations (GCSO) team. This position can be based at one of our UCB sites in Anderlecht (Belgium), Raleigh, NC (USA), Monheim am Rhein (Germany), or Slough (UK). About the role As a Senior Program Delivery Lead, you will provide strategic and operational leadership for complex global clinical development programs across all stages of development. You will drive the delivery of high-quality, patient-centric clinical studies, ensuring programs are executed efficiently, compliantly, and within budget and timelines. You will play a key role in shaping development strategies, managing stakeholders, and mentoring colleagues while contributing to innovative approaches that accelerate clinical development. Who you will work with You will collaborate closely with cross-functional experts across Clinical Development and CRO partners. You will also engage with investigators, external partners, patient advocacy groups, vendors, and Key Opinion Leaders to help deliver successful clinical development programs worldwide. What you will do * You will lead operational strategy and execution for global clinical development programs from Phase I through Phase IV. * You will develop and deliver program timelines, budgets, forecasts, and key milestones. * You will drive feasibility assessments, site strategies, and recruitment plans to support successful study delivery. * You will manage complex stakeholder relationships and ensure alignment across multidisciplinary teams. * You will champion patient-centricity, DE&I initiatives, and innovative approaches in clinical development. Interested? For this role, we are looking for the following education, experience, and skills: * Bachelor's degree required; Master's degree preferred, or equivalent experience in clinical development. * Extensive experience leading global clinical programs and complex clinical operations activities, including in cell and Gene Therapy would be ideal. * Strong knowledge of clinical development, ICH-GCP, regulations, and quality standards. * Demonstrated expertise in budget management, forecasting, feasibility, and risk management. * Proven ability to influence stakeholders and lead cross-functional teams in matrix organizations. * Excellent communication, coaching, presentation, and problem-solving skills in an international environment. Are you ready to 'go beyond' to create value and make your mark for patients? If this sounds like you, then we would love to hear from you! About us Why work with us? At UCB, we've embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless explicitly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office. UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable federal, state, or local law. UCB invites you to voluntarily self-identify during the application process. Provision of self-identification information is entirely voluntary and a decision to provide or not provide such information will not have any effect on your application for employment, your employment with UCB, or otherwise subject you to any adverse treatment. Any information you provide will be considered confidential and will be kept separate from your application and/or personnel file and will only be used in accordance with applicable laws, orders, and regulations. Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on US-Reasonable_Accommodation@ucb.com for application to US based roles. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel. | |
Aug 07, 2026